SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-19-015963
Filing Date
2019-08-15
Accepted
2019-08-15 08:49:20
Documents
10

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b4081419_delmarpharma.htm 424B4 1727997
2 GRAPHIC image_001.jpg GRAPHIC 27555
3 GRAPHIC image_002.jpg GRAPHIC 40622
4 GRAPHIC image_003.jpg GRAPHIC 137567
5 GRAPHIC image_004.jpg GRAPHIC 114299
6 GRAPHIC image_005.jpg GRAPHIC 30241
7 GRAPHIC image_006.jpg GRAPHIC 33770
8 GRAPHIC image_007.jpg GRAPHIC 68519
9 GRAPHIC image_008.jpg GRAPHIC 53642
10 GRAPHIC image_009.jpg GRAPHIC 21267
  Complete submission text file 0001213900-19-015963.txt   2456684
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B4 | Act: 33 | File No.: 333-232931 | Film No.: 191028577
SIC: 2834 Pharmaceutical Preparations